Atrovent®
ipratropium bromide
About Atrovent®
Prevention and treatment of shortness of breath in patients with chronic obstructive pulmonary disease (COPD) and mild to moderate bronchial asthma in adulthood and childhood as a supplement to beta-agonists in cases of acute asthma.
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
Chronic obstructive pulmonary disease (COPD) Chronic bronchitis Bronchial asthma
Brand Names
Atrovent®
Active ingredients
ipratropium bromide